Radiosynthesis of the anticancer nucleoside analogue Trifluridine using an automated 18F-trifluoromethylation procedure

Advances in [18F]Trifluoromethylation Chemistry for PET Imaging

Positron emission tomography (PET) is a preclinical and clinical imaging technique extensively used to study and visualize biological and physiological processes in vivo. Fluorine-18 (¹⁸F) is the most frequently used positron emitter for PET imaging due to its convenient 109.8 min half-life, high yield production on small biomedical cyclotrons, and well-established radiofluorination chemistry. The presence of fluorine atoms in many drugs opens new possibilities for developing radioligands labelled with fluorine-18. The trifluoromethyl group (CF₃) represents a versatile structural motif in medicinal and pharmaceutical chemistry to design and synthesize drug molecules with favourable pharmacological properties. This fact also makes CF₃ groups an exciting synthesis target from a PET tracer discovery perspective. Early attempts to synthesize [¹⁸F]CF₃-containing radiotracers were mainly hampered by low radiochemical yields and additional challenges such as low radiochemical purity and molar activity. However, recent innovations in [¹⁸F]trifluoromethylation chemistry have significantly expanded the chemical toolbox to synthesize fluorine-18-labelled radiotracers. This review presents the development of significant [¹⁸F]trifluoromethylation chemistry strategies to apply [¹⁸F]CF₃-containing radiotracers in preclinical and clinical PET imaging studies. The continuous growth of PET as a crucial functional imaging technique in biomedical and clinical research and the increasing number of CF₃-containing drugs will be the primary drivers for developing novel [¹⁸F]trifluoromethylation chemistry strategies in the future.

Synthesis and crystal structure of trifluoromethyl-containing bendamustine hydrochloride

A simple strategy to afford trifluoromethyl-containing bendamustine hydrochloride in 34% overall via nine simple steps including substitution, selective reduction, N-acylation, cyclization, esterification, nitro-reduction, N-dihydroxyethylation, chlorination, and acid-catalyzed hydrolysis from commercially available 2,4-dinitrochlorobenzene is described. The structures of the intermediates and target product are established on the basis of infrared, nuclear magnetic resonance, and high resolution mass spectrometer. Moreover, the structure of target product is also confirmed by X-ray crystal analysis, and further studies indicate that the existence of intermolecular O–H···Cl and N–H···Cl hydrogen bonds are effective in stabilization of the crystal structure.

Synthesis and Derivatization of 1,1-[18 F]Difluorinated Alkenes

A general method for the synthesis of 1,1-[¹⁸ F]difluorinated alkenes from [¹⁸ F]fluoride is reported. This transformation is highly regioselective giving the desired ¹⁸ F-fluoroalkenes with radiochemical purities of up to 77 % within 20 minutes and a molar activity (A_m ) of 1 GBq μmol^-1 . The transformations are operationally simple to perform and were readily translated onto a commercial automated synthesis unit. The resultant 1,1-[¹⁸ F]difluorinated alkene motif is prevalent in numerous drug molecules, and this is the first general method to synthesize this motif with fluorine-18. ¹⁸ F-fluorinated alkenes are excellent building blocks and participate in a number of post-labeling transformations to access a range of ¹⁸ F-perfluorinated functional groups that have never before been radiolabeled with non-carrier-added [¹⁸ F]fluoride. This method considerably expands the range of ¹⁸ F-motifs accessible to radiochemists.